Aptinyx Inc reported $-0.23 in EPS Earnings Per Share for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Eps Change
Acadia Pharmaceuticals ACAD:US USD 0 0
Acorda Therapeutics ACOR:US USD -0.57 2.58
Biogen BIIB:US USD 4.77 0.48
Cara Therapeutics CARA:US USD -0.43 0.35
Daiichi Sankyo 4568:JP JPY 14.81 5.77
Eli Lilly And LLY:US USD 2.09 0.11
Halozyme Therapeutics HALO:US USD 0.74 0.21
Intra Cellular Therapies ITCI:US USD -0.57 0.35
Marinus Pharmaceuticals MRNS:US USD -0.94 0.12
Neurocrine Biosciences NBIX:US USD 0.88 0.19
Novartis NOVN:VX USD 1.58 0.02
UCB UCB:BB EUR 2.05 0.47
Ultragenyx Pharmaceutical RARE:US USD -3.5 1.24
Vertex Pharmaceuticals VRTX:US USD 4.01 0.41